Thus, the relationship between IGF-1, insulin and BPH appears certain based upon the various journal reports and clinical investigations [12,35,43,44,45,46,47,48,49,50,51,52,53], which points to potential ways to therapeutically confront prostate disorders. Here, INS is linked to benign prostatic hyperplasia.